1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
AS ONE Corporation

AS ONE Corporation

IUSDF
AS ONE CorporationUS flagOther OTC
14.00
USD
- -
- -
997.75MMarket Cap
AS ONE Corporation
IUSDF
(Other OTC)

Recent

price

14.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
586.31
615.79
627.85
667.83
678.93
698.97
733.34
810.24
893.73
942.69
1,092.07
1,163
1,233.4
1,320.25
1,448.53
- -
640.29
Revenue per Share
32.13
37.25
41.87
46.8
50.48
50.6
55.22
62.27
70.5
79.9
80.14
96.34
109.45
103.65
114.89
- -
49.18
Basic EPS, GAAP
11.97
42.28
37.7
65.22
34.02
60.65
48.12
29.23
61.75
26.83
42.72
102.82
78.47
68.01
105.02
- -
- -
Free Cash Flow per Basic Share
13.27
9.5
13.75
13.74
18.98
21.77
26.02
28.36
34.56
38.58
34.31
47.36
50.99
56.63
59.11
- -
- -
Dividend per Share
414.59
447.76
475.88
508.94
538.97
567.84
599.71
642.01
682.83
724.14
769.39
817.86
854.83
908.16
973.26
- -
838.15
Book Value per Share
421.5
450.52
493.88
536.84
581.87
620.73
647.5
671.05
686.27
726
819.56
864.07
841.91
870.99
909.15
- -
797.05
Tangible Book Value per Share
78
77
77
77
77
77
76
75
75
75
75
75
74
72
72
- -
80
Basic Weighted Avg Shares
45,532
47,204
48,129
51,192
52,042
53,577
55,948
60,960
66,733
70,390
81,607
86,954
91,422
95,536
103,751
110,698
51,423
Sales/Revenue/Turnover
10.55
12.08
11.01
11.56
11.5
10.91
10.89
10.82
11.33
12.15
12.12
10.74
12.47
10.92
11.17
11.6
10.62
Operating Margin (%)
927
920
1,044
1,014
1,056
958
1,012
870
952
987
1,700
1,724
1,646
1,824
1,801
1,826
- -
Depreciation Expense
2,495
2,855
3,210
3,587
3,869
3,879
4,213
4,685
5,264
5,966
5,989
7,203
8,113
7,500
8,229
9,179
3,950
Net Income, GAAP
42.31
44.2
38.98
39.32
37.17
35.49
31.49
31.55
32.08
31.79
33.02
31.1
30.47
30.72
30.41
30.37
30.19
Effective Tax Rate (%)
5.48
6.05
6.67
7.01
7.43
7.24
7.53
7.68
7.89
8.48
7.34
8.28
8.87
7.85
7.93
8.29
7.68
Profit Margin (%)
26,482
27,468
31,845
30,194
29,257
32,847
28,312
28,414
24,717
26,002
33,126
34,183
35,355
35,128
43,463
47,259
36,119
Working Capital
9,275
8,675
8,075
5,175
4,275
3,375
2,475
2,000
1,100
950
3,100
1,500
3,438
2,313
4,752
2,630
1,625
LT Debt
34,629
36,880
39,682
42,660
45,850
48,615
50,169
52,467
53,252
56,494
62,762
66,154
63,968
64,661
66,708
71,176
65,613
Total Equity
6.27
6.58
6.66
7.2
7.33
7.08
7.63
8.08
9.05
9.96
10.21
9.17
11.07
10.17
11.05
11.58
5.4
Return on Invested Capital (%)
6.3
6.6
7.36
8.04
8.52
8.28
8.74
9.34
10.1
10.95
10.13
11.4
12.13
10.81
11.26
12.3
5.65
Return on Capital (%)
7.93
8.59
9.07
9.5
9.63
9.14
9.44
9.96
10.6
11.36
10.74
12.14
13.03
11.62
12.15
13.32
5.99
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
1,288
- -
1,263
LT Borrowings
2,313
- -
1,625
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
72
- -
72
Market Capitalization
- -
- -
267,129

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
61,229
- -
57,343
Cash, Cash Equivalents & STI
13,885
- -
15,154
Accounts Receivable, Net
22,186
- -
18,541
Inventories
10,831
- -
11,313
Total Current Liabilities
26,101
- -
21,225
Payables & Accruals
- -
- -
- -
ST Debt
1,288
- -
1,263
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.95%
2.61%
6.7%
Free Cash Flow
15.47%
20.68%
-50.58%
Net Income, GAAP
9.25%
9.32%
11.54%
Sales/Revenue/Turnover
7.58%
6.3%
6.7%
Total Cash Common Dividend
11.49%
13.37%
10.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
21,736
22,378
24,538
26,885
95,536
2025
- -
- -
- -
- -
103,751
2026
- -
- -
- -
- -
110,698

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24.4
- -
- -
- -
103.65
2025
- -
- -
- -
- -
114.89
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
56.63
2025
- -
- -
- -
- -
59.11
2026
- -
- -
- -
- -
- -
Similar Companies
Wajd life trading Company (9647.SR)
Saintmed Public Company Limited (SMD.BK)
Asker Healthcare Group AB (ASKER.ST)
Cencora, Inc. (0HF3.L)
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
WIN-Partners Co., Ltd. (3183.T)
Business
AS ONE Corporation (Ticker: IUSDF) manufactures and distributes a wide range of laboratory supplies, scientific instruments, and industrial equipment for research, healthcare, and manufacturing applications. The company offers core products including lab consumables such as pipettes, gloves, and Petri dishes; analytical instruments like microscopes, centrifuges, and spectrophotometers; precision tools and cleanroom supplies; and safety equipment encompassing fume hoods, protective apparel, and chemical storage solutions. These offerings cater to pharmaceutical, biotechnology, academic research, and industrial sectors primarily in Japan, with expanding operations across Asia, North America, and Europe. Founded in 1965 and headquartered in Osaka, Japan, AS ONE Corporation maintains a network of subsidiaries and distribution centers to support global supply chain efficiency.